10 Nov 2016

Catch a falling piano!

Last week Lupin announced that it had received USFDA approval to market a generic version of  Janssen Pharmaceuticals’ Otrho-Cyclon 28 oral contraceptive tablets to be manufactured at the company’s Pithampur facility. In the coming week we are likely to see equity markets cowering under cover until the outcome of the Presidential election is clear before reacting one way or the other. There is no clear consensus on how the markets will react either way, so the best tactic is probably not to try to catch a falling piano! 

No comments:

Post a Comment